Multiple sclerosis (MS) causes a wide range of symptoms involving the brain, optic nerves, and spinal cord. Research is only just beginning to reveal who is at risk and what causes the condition.
Multiple sclerosis (MS) causes a wide range of symptoms involving the brain, optic nerves, and spinal cord. Research is only just beginning to reveal who is at risk and what causes the condition.
The XVI edition of NCRM NICHE (www.ncrmniche.org), a one of its kind stem cells and regenerative medicine meet will be conducted on the 17th of October, 2021 in a hybrid mode from Japan with virtual telecast this year. The NCRM NICHE has been conducted annually for the past fifteen years having witnessed participation from scholars and experts from 180 institutes across 20 different countries, which has unique active knowledge gaining (AKG) events and Passive Knowledge gaining (PKG) events, incorporating the Edogawa NICHE Prize 2021 (www.edogawanicheprize.org). AKG event refers to any knowledge gaining activity in which the participant plays an active role.
Anti-inflammatory therapies could be effective at preventing heart disease in patients with clonal hematopoiesis, a common age-related blood condition, according to a new study published in Nature. The researchers identified how clonal hematopoiesis worsens atherosclerosis, and their findings suggest that an anti-inflammatory drug previously tested in a broader population of patients with cardiovascular disease may have potential for patients with atherosclerotic heart disease and clonal hematopoiesis. Thought to occur in roughly 10% of people over 70 years of age, clonal hematopoiesis occurs when hematopoietic stem cells (HSCs) acquire mutations.
An emerging new electrophysiology technology, known as high-density microelectrode arrays, enables researchers to study in vitro models of human brain disease in detail. This creates new possibilities to understand the underlying mechanisms of neurological disorders, like Parkinsons disease and amyotrophic lateral sclerosis, and advance therapy development
Introduction and scope: Stem Cell Characterization and Analysis Tool Market A comprehensive valuation study conducted for the Stem Cell Characterization and Analysis Tool market report reveals future growth prospects, trends, drivers and restraints, challenges, and opportunities. The market report presents a holistic approach in which statistical, analytical, historical, and economic data are exchanged.
Scientists at the Proteomics Core Unit of the Spanish National Cancer Research Centre (CNIO), headed by Javier Muoz, have clarified the mechanisms, unknown to date, included in maintaining embryonic stem cells in the best possible condition for their use in regenerative medicine. The results, published in Nature Communications, helps to find novel stem-cell therapies for brain stroke, heart disease or neurodegenerative conditions like Alzheimers or Parkinsons disease.
Fate Therapeutics long-standing Chief Scientific Officer Daniel Shoemaker, Ph.D., will be leaving the cell therapy biotech this summer. The biotech, which uses an induced pluripotent stem cell (iPSC) platform and is targeting off-the-shelf cell therapies for cancer, says he advised the company that he is retiring as of June 30, 2021, coming off a 12-year stint, spending half that time as its CSO.
There are some wonderful treatments for conditions once untreatable, based on the use of stem cells.
A SWOT Analysis ofVaccine, Insulin and Stem Cell, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down. The global Vaccine, Insulin and Stem Cell Market report offers a planned observation of analyzed data associated to Vaccine, Insulin and Stem Cell market. The Vaccine, Insulin and Stem Cell market report offers multiple opportunities to various industries, vendors, associations, and organizations offering items and administrations Geron Corporation., Cytori Therapeutics Inc., ImmunoCellular Therapeutics Ltd, Eli Lilly and Company, Novartis AG, Astellas Pharma, Osiris Therapeutics Inc., Aduro biotech, Biocon Ltd., Glaxo SmithKline PLC, Athersys, Ypsomed AG, Sanofi, Novo Nordisk A/S, Merck & CO., Fate Therapeutics Inc., INC.
As the name implies, induced pluripotent stem cells can become any type of cell in our body, and scientists have evidence that when they prompt them to become muscle progenitor cells they can help restore the sometimes debilitating muscle loss that happens with age. Progressive, age-related muscle loss is called sarcopenia, and it can impair mobility and quality of life, says Dr. Wanling Xuan, stem cell biologist in the Vascular Biology Center at the Medical College of Georgia
Recent Comments